ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 174 filers reported holding ACORDA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 2.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $16,000 | -30.4% | 30,924 | -0.0% | 0.00% | – |
| Q2 2020 | $23,000 | -64.1% | 30,930 | -54.8% | 0.00% | – |
| Q1 2020 | $64,000 | -88.9% | 68,489 | -75.8% | 0.00% | – |
| Q4 2019 | $577,000 | +14.5% | 283,058 | +61.0% | 0.00% | – |
| Q3 2019 | $504,000 | -46.2% | 175,781 | +44.1% | 0.00% | -100.0% |
| Q2 2019 | $936,000 | -40.6% | 121,969 | +2.8% | 0.00% | 0.0% |
| Q1 2019 | $1,577,000 | -15.1% | 118,670 | -0.5% | 0.00% | -50.0% |
| Q4 2018 | $1,858,000 | -28.7% | 119,248 | -10.0% | 0.00% | 0.0% |
| Q3 2018 | $2,605,000 | -21.9% | 132,555 | +14.1% | 0.00% | -33.3% |
| Q2 2018 | $3,335,000 | +28.2% | 116,208 | +5.6% | 0.00% | 0.0% |
| Q1 2018 | $2,602,000 | +12.6% | 110,024 | +2.1% | 0.00% | +50.0% |
| Q4 2017 | $2,310,000 | -5.8% | 107,710 | +3.9% | 0.00% | -33.3% |
| Q3 2017 | $2,452,000 | +34.9% | 103,683 | +12.4% | 0.00% | +50.0% |
| Q2 2017 | $1,818,000 | +14.6% | 92,261 | +22.1% | 0.00% | 0.0% |
| Q1 2017 | $1,587,000 | +65.7% | 75,550 | +48.2% | 0.00% | +100.0% |
| Q4 2016 | $958,000 | -8.8% | 50,981 | +1.2% | 0.00% | -50.0% |
| Q3 2016 | $1,051,000 | -17.5% | 50,356 | +0.8% | 0.00% | 0.0% |
| Q2 2016 | $1,274,000 | -8.2% | 49,936 | -4.9% | 0.00% | 0.0% |
| Q1 2016 | $1,388,000 | -37.9% | 52,490 | +0.4% | 0.00% | -50.0% |
| Q4 2015 | $2,236,000 | +91.1% | 52,258 | +18.4% | 0.00% | +100.0% |
| Q3 2015 | $1,170,000 | +16.8% | 44,149 | +46.9% | 0.00% | 0.0% |
| Q2 2015 | $1,002,000 | +6.0% | 30,064 | +5.8% | 0.00% | 0.0% |
| Q1 2015 | $945,000 | -16.8% | 28,403 | +2.2% | 0.00% | 0.0% |
| Q4 2014 | $1,136,000 | +31.3% | 27,787 | +8.8% | 0.00% | 0.0% |
| Q3 2014 | $865,000 | +17.4% | 25,544 | +16.8% | 0.00% | 0.0% |
| Q2 2014 | $737,000 | -14.0% | 21,865 | -3.3% | 0.00% | 0.0% |
| Q1 2014 | $857,000 | +43.8% | 22,607 | +10.7% | 0.00% | +100.0% |
| Q4 2013 | $596,000 | -10.8% | 20,419 | +4.6% | 0.00% | -50.0% |
| Q3 2013 | $668,000 | +19.1% | 19,521 | +14.9% | 0.00% | 0.0% |
| Q2 2013 | $561,000 | – | 16,995 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ORACLE INVESTMENT MANAGEMENT INC | 815,838 | $27,192,000 | 3.30% |
| ARMISTICE CAPITAL, LLC | 186,000 | $6,199,000 | 2.23% |
| 1492 Capital Management LLC | 95,639 | $3,188,000 | 2.02% |
| Partner Investment Management, L.P. | 19,498 | $650,000 | 0.91% |
| Tekla Capital Management LLC | 680,862 | $22,693,000 | 0.82% |
| PFM Health Sciences, LP | 817,396 | $27,244,000 | 0.69% |
| HighPoint Advisor Group LLC | 11,829 | $394,000 | 0.61% |
| ARBOR CAPITAL MANAGEMENT LLC | 89,183 | $2,972,000 | 0.56% |
| Pergamon Offshore Advisors, L.P. | 15,950 | $532,000 | 0.56% |
| Penn Capital Management Company, LLC | 390,212 | $13,006,000 | 0.54% |